Precision Optics Corporation, Inc. (POCI)
USD 4.04
(3.12%)
USD 4.04
(3.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 6.84 Million USD | -11.04% |
| 2023 | 7.69 Million USD | -0.5% |
| 2022 | 7.73 Million USD | 173.22% |
| 2021 | 2.83 Million USD | -20.94% |
| 2020 | 3.57 Million USD | -13.04% |
| 2019 | 4.11 Million USD | 111.37% |
| 2018 | 1.94 Million USD | 56.76% |
| 2017 | 1.24 Million USD | -19.11% |
| 2016 | 1.53 Million USD | 11.7% |
| 2015 | 1.37 Million USD | 25.47% |
| 2014 | 1.09 Million USD | 84.84% |
| 2013 | 592.88 Thousand USD | -18.46% |
| 2012 | 727.07 Thousand USD | -68.63% |
| 2011 | 2.31 Million USD | 10.73% |
| 2010 | 2.09 Million USD | 40.2% |
| 2009 | 1.49 Million USD | 69.73% |
| 2008 | 879.53 Thousand USD | 22.43% |
| 2007 | 718.38 Thousand USD | 22.04% |
| 2006 | 588.63 Thousand USD | 13.42% |
| 2005 | 519.01 Thousand USD | -12.53% |
| 2004 | 593.34 Thousand USD | 10.79% |
| 2003 | 535.57 Thousand USD | -29.92% |
| 2002 | 764.22 Thousand USD | -32.41% |
| 2001 | 1.13 Million USD | 33.88% |
| 2000 | 844.58 Thousand USD | 5.57% |
| 1999 | 800 Thousand USD | -20.0% |
| 1998 | 1 Million USD | 11.11% |
| 1997 | 900 Thousand USD | -43.75% |
| 1996 | 1.6 Million USD | 60.0% |
| 1995 | 1 Million USD | 11.11% |
| 1994 | 900 Thousand USD | -10.0% |
| 1993 | 1 Million USD | 42.86% |
| 1992 | 700 Thousand USD | -46.15% |
| 1991 | 1.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 7.37 Million USD | -4.11% |
| 2024 Q3 | 7.01 Million USD | 9.88% |
| 2024 Q2 | 6.38 Million USD | -13.52% |
| 2024 Q4 | 6.84 Million USD | -2.37% |
| 2023 Q2 | 7.61 Million USD | -7.05% |
| 2023 Q1 | 8.19 Million USD | 5.98% |
| 2023 FY | 7.69 Million USD | -0.5% |
| 2023 Q3 | 8.48 Million USD | 11.44% |
| 2023 Q4 | 7.69 Million USD | -9.36% |
| 2022 Q3 | 8.73 Million USD | 13.5% |
| 2022 FY | 7.73 Million USD | 173.22% |
| 2022 Q1 | 3.06 Million USD | 8.39% |
| 2022 Q2 | 7.69 Million USD | 150.99% |
| 2022 Q4 | 7.73 Million USD | -11.51% |
| 2021 Q3 | 2.45 Million USD | -20.28% |
| 2021 Q4 | 2.83 Million USD | 15.42% |
| 2021 FY | 2.83 Million USD | -20.94% |
| 2021 Q1 | 3.28 Million USD | -8.15% |
| 2021 Q2 | 3.07 Million USD | -6.45% |
| 2020 FY | 3.57 Million USD | -13.04% |
| 2020 Q1 | 2.59 Million USD | -37.05% |
| 2020 Q2 | 2.61 Million USD | 0.8% |
| 2020 Q3 | 3.06 Million USD | 17.47% |
| 2020 Q4 | 3.57 Million USD | 16.68% |
| 2019 FY | 4.11 Million USD | 111.37% |
| 2019 Q4 | 4.11 Million USD | 241.63% |
| 2019 Q1 | 1.7 Million USD | -12.53% |
| 2019 Q2 | 1.39 Million USD | -18.2% |
| 2019 Q3 | 1.2 Million USD | -13.53% |
| 2018 Q4 | 1.94 Million USD | 21.24% |
| 2018 FY | 1.94 Million USD | 56.76% |
| 2018 Q1 | 1.11 Million USD | -9.99% |
| 2018 Q2 | 1.54 Million USD | 38.51% |
| 2018 Q3 | 1.6 Million USD | 3.7% |
| 2017 Q3 | 1.27 Million USD | -9.0% |
| 2017 Q2 | 1.4 Million USD | -11.36% |
| 2017 FY | 1.24 Million USD | -19.11% |
| 2017 Q1 | 1.58 Million USD | 3.22% |
| 2017 Q4 | 1.24 Million USD | -2.84% |
| 2016 Q3 | 1.35 Million USD | 7.32% |
| 2016 Q1 | 1.33 Million USD | -2.77% |
| 2016 Q4 | 1.53 Million USD | 13.53% |
| 2016 FY | 1.53 Million USD | 11.7% |
| 2016 Q2 | 1.26 Million USD | -5.7% |
| 2015 Q1 | 851.41 Thousand USD | -22.31% |
| 2015 Q4 | 1.37 Million USD | 5.03% |
| 2015 Q3 | 1.3 Million USD | -6.71% |
| 2015 FY | 1.37 Million USD | 25.47% |
| 2015 Q2 | 1.4 Million USD | 64.82% |
| 2014 Q3 | 919.07 Thousand USD | 39.87% |
| 2014 Q4 | 1.09 Million USD | 19.24% |
| 2014 FY | 1.09 Million USD | 84.84% |
| 2014 Q2 | 657.07 Thousand USD | 2.24% |
| 2014 Q1 | 642.65 Thousand USD | 8.39% |
| 2013 Q2 | 1.16 Million USD | 17.89% |
| 2013 FY | 592.88 Thousand USD | -18.46% |
| 2013 Q4 | 592.88 Thousand USD | -9.88% |
| 2013 Q3 | 657.92 Thousand USD | -43.3% |
| 2013 Q1 | 984.22 Thousand USD | 35.37% |
| 2012 Q1 | 2 Million USD | -13.39% |
| 2012 Q3 | 625.96 Thousand USD | 24.94% |
| 2012 Q2 | 501.02 Thousand USD | -75.04% |
| 2012 FY | 727.07 Thousand USD | -68.63% |
| 2012 Q4 | 727.07 Thousand USD | 16.15% |
| 2011 FY | 2.31 Million USD | 10.73% |
| 2011 Q2 | 1.98 Million USD | -2.73% |
| 2011 Q1 | 2.03 Million USD | -2.54% |
| 2011 Q3 | 2.27 Million USD | 14.56% |
| 2011 Q4 | 2.31 Million USD | 1.96% |
| 2010 Q3 | 2.04 Million USD | 15.17% |
| 2010 FY | 2.09 Million USD | 40.2% |
| 2010 Q4 | 2.09 Million USD | 2.34% |
| 2010 Q2 | 1.77 Million USD | 18.1% |
| 2010 Q1 | 1.5 Million USD | 0.71% |
| 2009 Q4 | 1.49 Million USD | 6.93% |
| 2009 FY | 1.49 Million USD | 69.73% |
| 2009 Q2 | 1.19 Million USD | 18.9% |
| 2009 Q3 | 1.39 Million USD | 16.58% |
| 2009 Q1 | 1 Million USD | 14.51% |
| 2008 Q2 | 535.91 Thousand USD | 5.12% |
| 2008 Q3 | 612.62 Thousand USD | 14.31% |
| 2008 Q4 | 879.53 Thousand USD | 43.57% |
| 2008 Q1 | 509.82 Thousand USD | -29.03% |
| 2008 FY | 879.53 Thousand USD | 22.43% |
| 2007 Q3 | 957.98 Thousand USD | 52.55% |
| 2007 Q4 | 718.38 Thousand USD | -25.01% |
| 2007 FY | 718.38 Thousand USD | 22.04% |
| 2007 Q1 | 545.39 Thousand USD | -7.35% |
| 2007 Q2 | 627.99 Thousand USD | 15.15% |
| 2006 Q4 | 588.63 Thousand USD | -10.75% |
| 2006 Q2 | 482.75 Thousand USD | -15.65% |
| 2006 Q1 | 572.34 Thousand USD | 10.28% |
| 2006 FY | 588.63 Thousand USD | 13.42% |
| 2006 Q3 | 659.51 Thousand USD | 36.62% |
| 2005 FY | 519.01 Thousand USD | -12.53% |
| 2005 Q1 | 592.53 Thousand USD | -0.14% |
| 2005 Q3 | 515.01 Thousand USD | -5.15% |
| 2005 Q4 | 519.01 Thousand USD | 0.78% |
| 2005 Q2 | 543 Thousand USD | -8.36% |
| 2004 Q1 | 747.56 Thousand USD | 39.58% |
| 2004 FY | 593.34 Thousand USD | 10.79% |
| 2004 Q4 | 593.34 Thousand USD | 30.34% |
| 2004 Q3 | 455.21 Thousand USD | 11.8% |
| 2004 Q2 | 407.16 Thousand USD | -45.53% |
| 2003 FY | 535.57 Thousand USD | -29.92% |
| 2003 Q4 | 535.57 Thousand USD | -9.31% |
| 2003 Q3 | 590.56 Thousand USD | 8.28% |
| 2003 Q2 | 545.39 Thousand USD | -43.66% |
| 2003 Q1 | 968.13 Thousand USD | 26.68% |
| 2002 FY | 764.22 Thousand USD | -32.41% |
| 2002 Q4 | 764.22 Thousand USD | -26.28% |
| 2002 Q3 | 1.03 Million USD | -0.97% |
| 2002 Q2 | 1.04 Million USD | 55.32% |
| 2002 Q1 | 673.95 Thousand USD | -40.4% |
| 2001 Q2 | 708.41 Thousand USD | -5.68% |
| 2001 Q4 | 1.13 Million USD | 33.05% |
| 2001 FY | 1.13 Million USD | 33.88% |
| 2001 Q1 | 751.05 Thousand USD | -11.07% |
| 2001 Q3 | 849.9 Thousand USD | 19.97% |
| 2000 Q2 | 1 Million USD | 0.0% |
| 2000 FY | 844.58 Thousand USD | 5.57% |
| 2000 Q3 | 1.06 Million USD | 6.87% |
| 2000 Q1 | 1 Million USD | 25.0% |
| 2000 Q4 | 844.58 Thousand USD | -20.97% |
| 1999 Q4 | 800 Thousand USD | -11.11% |
| 1999 FY | 800 Thousand USD | -20.0% |
| 1999 Q1 | 700 Thousand USD | -30.0% |
| 1999 Q2 | 800 Thousand USD | 14.29% |
| 1999 Q3 | 900 Thousand USD | 12.5% |
| 1998 Q1 | 800 Thousand USD | -11.11% |
| 1998 Q4 | 1 Million USD | 11.11% |
| 1998 Q3 | 900 Thousand USD | 0.0% |
| 1998 Q2 | 900 Thousand USD | 12.5% |
| 1998 FY | 1 Million USD | 11.11% |
| 1997 Q2 | 1 Million USD | -23.08% |
| 1997 Q4 | 900 Thousand USD | -10.0% |
| 1997 FY | 900 Thousand USD | -43.75% |
| 1997 Q1 | 1.3 Million USD | -18.75% |
| 1997 Q3 | 1 Million USD | 0.0% |
| 1996 FY | 1.6 Million USD | 60.0% |
| 1996 Q3 | 1.4 Million USD | 27.27% |
| 1996 Q1 | 900 Thousand USD | -10.0% |
| 1996 Q2 | 1.1 Million USD | 22.22% |
| 1996 Q4 | 1.6 Million USD | 14.29% |
| 1995 Q3 | 900 Thousand USD | 28.57% |
| 1995 Q4 | 1 Million USD | 11.11% |
| 1995 Q2 | 700 Thousand USD | 0.0% |
| 1995 Q1 | 700 Thousand USD | -22.22% |
| 1995 FY | 1 Million USD | 11.11% |
| 1994 Q2 | 800 Thousand USD | 0.0% |
| 1994 Q3 | 800 Thousand USD | 0.0% |
| 1994 Q4 | 900 Thousand USD | 12.5% |
| 1994 FY | 900 Thousand USD | -10.0% |
| 1994 Q1 | 800 Thousand USD | -20.0% |
| 1993 Q3 | 700 Thousand USD | -12.5% |
| 1993 Q2 | 800 Thousand USD | 60.0% |
| 1993 Q1 | 500 Thousand USD | -28.57% |
| 1993 FY | 1 Million USD | 42.86% |
| 1993 Q4 | 1 Million USD | 42.86% |
| 1992 FY | 700 Thousand USD | -46.15% |
| 1992 Q4 | 700 Thousand USD | 0.0% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q4 | 1.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 94.593% |
| AngioDynamics, Inc. | 112.08 Million USD | 93.893% |
| AtriCure, Inc. | 147.76 Million USD | 95.368% |
| Avinger, Inc. | 19.97 Million USD | 65.728% |
| Azenta, Inc. | 351.22 Million USD | 98.051% |
| BioLife Solutions, Inc. | 75.05 Million USD | 90.88% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.833% |
| Daxor Corporation | 858.75 Thousand USD | -697.056% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 58.038% |
| Femasys Inc. | 9.4 Million USD | 27.208% |
| GlucoTrack, Inc. | 1.7 Million USD | -300.749% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 89.354% |
| Hologic, Inc. | 4.02 Billion USD | 99.83% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.696% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.665% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 15.572% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 85.996% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -937.189% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -937.189% |
| Masimo Corporation | 1.67 Billion USD | 99.592% |
| Microbot Medical Inc. | 3.82 Million USD | -78.902% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 72.705% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.391% |
| Nephros, Inc. | 3.5 Million USD | -95.398% |
| NovoCure Limited | 783.63 Million USD | 99.127% |
| NEXGEL, Inc. | 4.78 Million USD | -42.927% |
| NEXGEL, Inc. | 4.78 Million USD | -42.927% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 92.083% |
| OraSure Technologies, Inc. | 52.17 Million USD | 86.881% |
| Pro-Dex, Inc. | 23.34 Million USD | 70.677% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 58.375% |
| Predictive Oncology Inc. | 6.14 Million USD | -11.379% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.808% |
| Repligen Corporation | 853.2 Million USD | 99.198% |
| Sanara MedTech Inc. | 29.28 Million USD | 76.625% |
| STAAR Surgical Company | 102.73 Million USD | 93.338% |
| Sharps Technology, Inc. | 3.85 Million USD | -77.557% |
| Utah Medical Products, Inc. | 7.14 Million USD | 4.202% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.832% |
| Jin Medical International Ltd. | 8.92 Million USD | 23.302% |